The current landscape of multiple myeloma treatment

Leuk Res. 2008 Dec:32 Suppl 1:S1-24. doi: 10.1016/S0145-2126(08)70002-X.
No abstract available

Publication types

  • Congress

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant / methods
  • Chemotherapy, Adjuvant / trends
  • Combined Modality Therapy
  • Drug Resistance, Neoplasm / drug effects
  • Humans
  • Lenalidomide
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / mortality
  • Multiple Myeloma / therapy*
  • Patient Selection
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Stem Cell Transplantation / trends
  • Survival Analysis
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives
  • Transplantation, Autologous

Substances

  • Thalidomide
  • Lenalidomide